Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Citi
Healthtrust
Moodys
Queensland Health
Colorcon
Accenture
UBS
Farmers Insurance
Merck

Generated: October 21, 2017

DrugPatentWatch Database Preview

IRINOTECAN HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Irinotecan Hydrochloride, and what generic Irinotecan Hydrochloride alternatives are available?

Irinotecan Hydrochloride is a drug marketed by Teva Pharms Usa, Sun Pharma Global, Hospira, Hisun Pharm Hangzhou, Cipla Ltd, Pliva Lachema, Akorn, Hikma Farmaceutica, Ingenus Pharms Llc, Sandoz Inc, Dr Reddys Labs Ltd, West-ward Pharms Int, Intas Pharms Usa, Accord Hlthcare, Emcure Pharms Ltd, Jiangsu Hengrui Med, Fresenius Kabi Usa, Qilu Pharm Co Ltd, Fresenius Kabi Oncol, Actavis Totowa, Mustafa Nevzat Ilac, and Sandoz. and is included in twenty-three NDAs.

The generic ingredient in IRINOTECAN HYDROCHLORIDE is irinotecan hydrochloride. There are thirty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the irinotecan hydrochloride profile page.

Summary for Tradename: IRINOTECAN HYDROCHLORIDE

US Patents:0
Applicants:22
NDAs:23
Suppliers / Packagers: see list13
Bulk Api Vendors: see list48
Clinical Trials: see list3,158
Patent Applications: see list3,392
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IRINOTECAN HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: IRINOTECAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION078589-001Feb 27, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui Med
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION090675-002Dec 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Mustafa Nevzat Ilac
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION090393-003May 13, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION079068-001Nov 21, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Jiangsu Hengrui Med
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION090675-001Dec 16, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION079068-002Nov 21, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION090101-002Feb 27, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Ingenus Pharms Llc
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION206935-001May 26, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION078753-001Dec 24, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Oncol
IRINOTECAN HYDROCHLORIDE
irinotecan hydrochloride
INJECTABLE;INJECTION078188-001Feb 27, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
US Department of Justice
Argus Health
Healthtrust
Boehringer Ingelheim
AstraZeneca
Teva
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot